Skip to main content
. 2019 Dec 18;2019(12):CD011016. doi: 10.1002/14651858.CD011016.pub2

ISRCTN11797545.

Trial name or title Public title: evaluation of combined Eyepeace and Eye Nutrients study
Scientific title: Investigate the improvements in tear film/ocular surface and visual recovery in laser and intraocular lens (IOL) refractive surgery patients preoperative using the Eyepeace (Eyelid massager) and Eye Nutrients (omega fatty acid supplement)
Methods Study design: randomized, parallel‐group, controlled trial
Study site(s): not reported
Number randomized (total and per group): 225 participants (planned)
Unit of randomization (individual or eye): not reported
Exclusions after randomization: not reported
Losses to follow‐up: not reported
Number analyzed (total and per group): not reported
Unit of analysis (individual or eye): not reported
Reported power calculation? (Y/N): N
Reported subgroup analysis? (Y/N): N
Participants Participant characteristics
Country: United Kingdom
Age (mean ± SD, range): 18 years of age or older (planned)
Gender: both (planned)
Inclusion criteria: aged 18 or overHave otherwise healthy eyes; are prepared not to wear contact lens for 3 months of the trial; have a NITBUT <10s; OSDI score: greater than or equal to 12; symptom frequency at least "some of the time"; presence of cloudy fluid expressed from at least 1 of the central 8 glands on the lower/upper lid and/or presence of poor expressibility from at least 2‐3 of the central 8 glands on the lower lid
Exclusion criteria: conjunctivitis; meibomian cysts; styes; damage to the cornea; ocular injury; cataract or laser refractive surgery in the past 6 months; increased intraocular pressure (primary or secondary); any chronic disease of the eye
Equivalence of baseline characteristics? (Y/N): not reported
Interventions Intervention #1: Eyepeace eyelid massage: once a day, to be started 1 week prior to laser or intraocular lens surgery, to be stopped one day prior to surgery
eye nutrients: two capsules a day, to be started 1 week prior to laser or intraocular lens surgery, to be stopped 3 months after surgery
Intervention #2: eye nutrients: two capsules a day, to be started 1 week prior to laser or intraocular lens surgery, to be stopped 3 months after surgery
Intervention #3: no Eyepeace or eye nutrients
Length of follow‐up: 3 months
Notes: none
Outcomes Primary outcome(s): tear film lipid layer thickness
Secondary outcome(s): TBUT; meibomian gland function; ocular redness/hyperaemia; MMP‐9; corneal sensitivity; corneal staining; tear volume; dry eye symptoms; visual satisfaction; longitudinal progress of the patient’s dry eye symptoms and adherence to dry eye treatment,
Adverse events reported? (Y/N): not reported
Measurement time points (specify intervals at which outcomes were assessed):2 weeks, 1 month, 2 months and 3 months
Other issues with outcome assessment (eg, quality control for outcomes, if any): none
Starting date March 2018
Contact information Proffesor Jonathan Moore
Cathedral Eye Clinic 89‐91 Academy Street, Belfast, BT1 2LS, United Kingdom
Notes Date of last participant enrollment: April 1, 2018
Date clinical trial registry last updated: February 13, 2018
Recruitment status: no longer recruiting
Other notes: study sponsored by Cathedral Eye Research